Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease prevalence » increased prevalence (Expand Search), disease prevalence (Expand Search), increasing prevalence (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
threat decrease » largest decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease prevalence » increased prevalence (Expand Search), disease prevalence (Expand Search), increasing prevalence (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
threat decrease » largest decrease (Expand Search)
-
141
-
142
Assessment of the predicted three-dimensional structures of tBLIP-II, tBLIP-II-CPP, and CPP-BLIP-II.
Published 2024Subjects: -
143
-
144
Determination of IC<sub>50</sub> values for tBLIP-II, tBLIP-II-CPP, and CPP-tBLIP-II.
Published 2024Subjects: -
145
The results of the cytotoxic and hemolytic activities of tBLIP-II and tBLIP-II-CPP.
Published 2024Subjects: -
146
-
147
-
148
-
149
-
150
Significantly Enriched Pathways.
Published 2025“…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …”
-
151
Exercise is associated with a decrease in BMI.
Published 2022“…<p>There was a significant association between a greater number of exercise sessions attended and decreased BMI over the 6-month intervention period.…”
-
152
-
153
datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf
Published 2020“…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
-
154
datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf
Published 2020“…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
-
155
datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf
Published 2020“…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
-
156
-
157
-
158
-
159
-
160